Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes
**Background:** Single-tablet combination therapies (STCTs) combine multiple drugs into one formulation, making drug administration more convenient for patients. STCTs were developed to address concerns with treatment adherence and persistence, but the impact of STCT use is not fully understood acro...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2024-01-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.91396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860289199669248 |
|---|---|
| author | Carly J. Paoli Jörg Linder Khushboo Gurjar Deepika Thakur Julie Wyckmans Stacy Grieve |
| author_facet | Carly J. Paoli Jörg Linder Khushboo Gurjar Deepika Thakur Julie Wyckmans Stacy Grieve |
| author_sort | Carly J. Paoli |
| collection | DOAJ |
| description | **Background:** Single-tablet combination therapies (STCTs) combine multiple drugs into one formulation, making drug administration more convenient for patients. STCTs were developed to address concerns with treatment adherence and persistence, but the impact of STCT use is not fully understood across indications.
**Objectives:** We conducted a systematic literature review (SLR) to examine STCT-associated outcomes across 4 evidence domains: clinical trials, real-world evidence (RWE), health-related quality of life (HRQoL) studies, and economic evaluations.
**Methods:** Four SLRs were conducted across the aforementioned domains. Included studies compared STCTs as well as fixed-dose combinations (\[FDCs\] of non-tablet formulations) with the equivalent active compounds and doses in loose-dose combinations (LDCs). Original research articles were included; case reports, case series, and non-English-language sources were excluded. Databases searched included EconLit, Embase, and Ovid MEDLINE® ALL. Two independent reviewers assessed relevant studies and extracted data. Conflicts were resolved with a third reviewer or consensus-based discussion.
**Results:** In all, 109 studies were identified; 27 studies were identified in more than one SLR. Treatment adherence was significantly higher in patients receiving FDCs vs LDCs in 12 of 13 RWE studies and 3 of 13 clinical trials. All 18 RWE studies reported higher persistence with FDCs. In RWE studies examining clinical outcomes (n = 17), 14 reported positive findings with FDCs, including a reduced need for add-on medication, blood pressure control, and improved hemoglobin A1C. HRQoL studies generally reported numerical improvements with STCTs or similarities between STCTs and LDCs. Economic outcomes favored STCT use. All 6 cost-effectiveness or cost-utility analyses found FDCs were less expensive and more efficacious than LDCs. Four budget impact models found that STCTs were associated with cost savings. Medical costs and healthcare resource use were generally lower with FDCs than with LDCs.
**Discussion:** Evidence from RWE and economic studies strongly favored STCT use, while clinical trials and HRQoL studies primarily reported similarity between STCTs and LDCs. This may be due to clinical trial procedures aimed at maximizing adherence and HRQoL measures that are not designed to evaluate drug administration.
**Conclusions:** Our findings highlight the value of STCTs for improving patient adherence, persistence, and clinical outcomes while also offering economic advantages. |
| format | Article |
| id | doaj-art-701d54af49e748dab6df60da55501abd |
| institution | Kabale University |
| issn | 2327-2236 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Columbia Data Analytics, LLC |
| record_format | Article |
| series | Journal of Health Economics and Outcomes Research |
| spelling | doaj-art-701d54af49e748dab6df60da55501abd2025-02-10T16:13:18ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362024-01-01111Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic OutcomesCarly J. PaoliJörg LinderKhushboo GurjarDeepika ThakurJulie WyckmansStacy Grieve**Background:** Single-tablet combination therapies (STCTs) combine multiple drugs into one formulation, making drug administration more convenient for patients. STCTs were developed to address concerns with treatment adherence and persistence, but the impact of STCT use is not fully understood across indications. **Objectives:** We conducted a systematic literature review (SLR) to examine STCT-associated outcomes across 4 evidence domains: clinical trials, real-world evidence (RWE), health-related quality of life (HRQoL) studies, and economic evaluations. **Methods:** Four SLRs were conducted across the aforementioned domains. Included studies compared STCTs as well as fixed-dose combinations (\[FDCs\] of non-tablet formulations) with the equivalent active compounds and doses in loose-dose combinations (LDCs). Original research articles were included; case reports, case series, and non-English-language sources were excluded. Databases searched included EconLit, Embase, and Ovid MEDLINE® ALL. Two independent reviewers assessed relevant studies and extracted data. Conflicts were resolved with a third reviewer or consensus-based discussion. **Results:** In all, 109 studies were identified; 27 studies were identified in more than one SLR. Treatment adherence was significantly higher in patients receiving FDCs vs LDCs in 12 of 13 RWE studies and 3 of 13 clinical trials. All 18 RWE studies reported higher persistence with FDCs. In RWE studies examining clinical outcomes (n = 17), 14 reported positive findings with FDCs, including a reduced need for add-on medication, blood pressure control, and improved hemoglobin A1C. HRQoL studies generally reported numerical improvements with STCTs or similarities between STCTs and LDCs. Economic outcomes favored STCT use. All 6 cost-effectiveness or cost-utility analyses found FDCs were less expensive and more efficacious than LDCs. Four budget impact models found that STCTs were associated with cost savings. Medical costs and healthcare resource use were generally lower with FDCs than with LDCs. **Discussion:** Evidence from RWE and economic studies strongly favored STCT use, while clinical trials and HRQoL studies primarily reported similarity between STCTs and LDCs. This may be due to clinical trial procedures aimed at maximizing adherence and HRQoL measures that are not designed to evaluate drug administration. **Conclusions:** Our findings highlight the value of STCTs for improving patient adherence, persistence, and clinical outcomes while also offering economic advantages.https://doi.org/10.36469/001c.91396 |
| spellingShingle | Carly J. Paoli Jörg Linder Khushboo Gurjar Deepika Thakur Julie Wyckmans Stacy Grieve Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes Journal of Health Economics and Outcomes Research |
| title | Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes |
| title_full | Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes |
| title_fullStr | Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes |
| title_full_unstemmed | Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes |
| title_short | Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes |
| title_sort | effectiveness of single tablet combination therapy in improving adherence and persistence and the relation to clinical and economic outcomes |
| url | https://doi.org/10.36469/001c.91396 |
| work_keys_str_mv | AT carlyjpaoli effectivenessofsingletabletcombinationtherapyinimprovingadherenceandpersistenceandtherelationtoclinicalandeconomicoutcomes AT jorglinder effectivenessofsingletabletcombinationtherapyinimprovingadherenceandpersistenceandtherelationtoclinicalandeconomicoutcomes AT khushboogurjar effectivenessofsingletabletcombinationtherapyinimprovingadherenceandpersistenceandtherelationtoclinicalandeconomicoutcomes AT deepikathakur effectivenessofsingletabletcombinationtherapyinimprovingadherenceandpersistenceandtherelationtoclinicalandeconomicoutcomes AT juliewyckmans effectivenessofsingletabletcombinationtherapyinimprovingadherenceandpersistenceandtherelationtoclinicalandeconomicoutcomes AT stacygrieve effectivenessofsingletabletcombinationtherapyinimprovingadherenceandpersistenceandtherelationtoclinicalandeconomicoutcomes |